[Opinion] Should the 90% CI for GMR be required to encompass 1 [RSABE / ABEL]

posted by jag009  – NJ, 2018-03-29 21:22 (1348 d 23:13 ago) – Posting: # 18621
Views: 8,472

If I recall (or I am imagining things), FDA published a paper about NTI drug BE assessment (Helmut, help! Am I hallucinating again?)

Anyhow, Have you looked at this FDA slide presentation before?

NTI

John

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 9 (0 registered, 9 guests [including 8 identified bots]).
Forum time: Tuesday 19:35 CET (Europe/Vienna)

A big computer, a complex algorithm and a long time
does not equal science.    Robert Gentleman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5